Seegene Awarded Patent for Haplotyping Using Multiplex PCR
Haplotyping genetic screening technique promises to accelerate detection of unique personal traits for disease risk and drug response
23-Dec-2008 -
Seegene, Inc announced that it has been awarded international patent protection for a break-through technology able to accelerate the detection of highly personal variations in genetic sequences. These genetic variations can identify an individual's risks for a broad range of disorders, such as ...
Alzheimer's disease
Bio-Medical Research
diseases
+3